Joyce Lii

2.3k total citations · 1 hit paper
54 papers, 1.6k citations indexed

About

Joyce Lii is a scholar working on Economics and Econometrics, Oncology and Surgery. According to data from OpenAlex, Joyce Lii has authored 54 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 11 papers in Oncology and 10 papers in Surgery. Recurrent topics in Joyce Lii's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Breast Cancer Treatment Studies (7 papers) and Pharmaceutical Economics and Policy (7 papers). Joyce Lii is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Breast Cancer Treatment Studies (7 papers) and Pharmaceutical Economics and Policy (7 papers). Joyce Lii collaborates with scholars based in United States, Canada and Thailand. Joyce Lii's co-authors include Michael A. Fischer, William H. Shrank, M. Alan Brookhart, Joel S. Weissman, Margaret Stedman, Christine Vogeli, Niteesh K. Choudhry, Daniel H. Solomon, Sebastian Schneeweiß and Seoyoung C. Kim and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Joyce Lii

48 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Primary Medication Non-Adherence: Analysis of 195,930 Electronic Prescriptions

2010 428 citations Michael A. Fischer, Joyce Lii et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joyce Lii United States	21	422	369	288	260	253	54	1.6k
Kristijan H. Kahler United States	27	625 1.5×	583 1.6×	192 0.7×	480 1.8×	309 1.2×	72	2.9k
Anita Burrell United States	9	815 1.9×	383 1.0×	120 0.4×	139 0.5×	272 1.1×	22	2.0k
Yu Ko Taiwan	27	260 0.6×	278 0.8×	97 0.3×	286 1.1×	446 1.8×	86	1.8k
Pamala A. Pawloski United States	27	266 0.6×	253 0.7×	687 2.4×	405 1.6×	198 0.8×	99	2.5k
Joel M. Schectman United States	24	352 0.8×	240 0.7×	311 1.1×	282 1.1×	193 0.8×	36	3.4k
Jacques LeLorier Canada	13	262 0.6×	526 1.4×	145 0.5×	434 1.7×	201 0.8×	24	1.8k
Gregory Brill United States	21	310 0.7×	258 0.7×	92 0.3×	111 0.4×	176 0.7×	54	1.2k
Mike Crilly United Kingdom	16	205 0.5×	264 0.7×	221 0.8×	74 0.3×	156 0.6×	46	1.5k
Marie Paule Schneider Switzerland	20	627 1.5×	151 0.4×	103 0.4×	71 0.3×	380 1.5×	110	1.7k
Lin Xie United States	23	180 0.4×	170 0.5×	213 0.7×	137 0.5×	81 0.3×	88	1.4k

Countries citing papers authored by Joyce Lii

Since Specialization

Citations

This map shows the geographic impact of Joyce Lii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joyce Lii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joyce Lii more than expected).

Fields of papers citing papers by Joyce Lii

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joyce Lii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joyce Lii. The network helps show where Joyce Lii may publish in the future.

Co-authorship network of co-authors of Joyce Lii

This figure shows the co-authorship network connecting the top 25 collaborators of Joyce Lii. A scholar is included among the top collaborators of Joyce Lii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joyce Lii. Joyce Lii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feldman, William B., Mufaddal Mahesri, Ameet Sarpatwari, et al.. (2024). Removing the FDA’s Boxed Hepatotoxicity Warning and Liver Function Testing Requirement for Ambrisentan. JAMA Network Open. 7(7). e2419873–e2419873.

Zhang, Yichi, Yinzhu Jin, Shirley Wang, et al.. (2023). Comparison of EHR Data-Completeness in Patients with Different Types of Medical Insurance Coverage in the United States. SSRN Electronic Journal. 2 indexed citations

Ganguli, Ishani, E. John Orav, Joyce Lii, et al.. (2023). Patient Characteristics Associated With Being Offered or Choosing Telephone vs Video Virtual Visits Among Medicare Beneficiaries. JAMA Network Open. 6(3). e235242–e235242. 24 indexed citations

Schneeweiß, Sebastian, et al.. (2022). Advancing an Algorithm for the Identification of Patients with High Data-Continuity in Electronic Health Records. Clinical Epidemiology. Volume 14. 1339–1349. 5 indexed citations

Schneeweiß, Sebastian, et al.. (2022). An algorithm to predict data completeness in oncology electronic medical records for comparative effectiveness research. Annals of Epidemiology. 76. 143–149.

Gopalakrishnan, Chandrasekar, Rishi Desai, Jessica M. Franklin, et al.. (2021). Development of a Medicare Claims–Based Model to Predict Persistent High‐Dose Opioid Use After Total Knee Replacement. Arthritis Care & Research. 74(8). 1342–1348. 4 indexed citations

Fischer, Michael A., Mufaddal Mahesri, Joyce Lii, & Jeffrey A. Linder. (2021). Non-Visit-Based and Non-Infection-Related Antibiotic Use in the US: A Cohort Study of Privately Insured Patients During 2016–2018. Open Forum Infectious Diseases. 8(9). ofab412–ofab412. 5 indexed citations

Liew, Jean W., Seoyoung C. Kim, Christine Peloquin, et al.. (2021). Knee osteonecrosis incidence from two real-world data sources. SHILAP Revista de lepidopterología. 3(2). 100169–100169. 2 indexed citations

Lin, Kueiyu Joshua, Sebastian Schneeweiß, Helen Tesfaye, et al.. (2020). Pharmacotherapy for Hospitalized Patients with COVID-19: Treatment Patterns by Disease Severity. Drugs. 80(18). 1961–1972. 23 indexed citations

10.

Wang, Shirley, Martin Kulldorff, Stephen Poor, et al.. (2020). Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration. Ophthalmology. 128(2). 248–255. 8 indexed citations

11.

Desai, Rishi, Ameet Sarpatwari, Sara Z. Dejene, et al.. (2019). Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims. PLoS Medicine. 16(3). e1002763–e1002763. 49 indexed citations

12.

Jin, Yinzhu, et al.. (2019). Patterns of prescription opioid use before total hip and knee replacement among US Medicare enrollees. Osteoarthritis and Cartilage. 27(10). 1445–1453. 25 indexed citations

13.

Freedman, Rachel A., Nancy L. Keating, Nancy U. Lin, et al.. (2018). Breast cancer‐specific survival by age: Worse outcomes for the oldest patients. Cancer. 124(10). 2184–2191. 55 indexed citations

14.

Desai, Rishi, Ameet Sarpatwari, Sara Z. Dejene, et al.. (2018). Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study. BMJ. 361. k1180–k1180. 25 indexed citations

15.

Kim, Seoyoung C., Niteesh K. Choudhry, Jessica M. Franklin, et al.. (2017). Patterns and predictors of persistent opioid use following hip or knee arthroplasty. Osteoarthritis and Cartilage. 25(9). 1399–1406. 143 indexed citations

16.

Gagne, Joshua J., Jennifer M. Polinski, Wenlei Jiang, et al.. (2017). Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence. Drugs. 77(4). 427–433. 8 indexed citations

17.

Freedman, Rachel A., Elena M. Kouri, Dee W. West, et al.. (2015). Higher Stage of Disease Is Associated With Bilateral Mastectomy Among Patients With Breast Cancer: A Population-Based Survey. Clinical Breast Cancer. 16(2). 105–112. 10 indexed citations

18.

Solomon, Daniel H., Jeffrey R. Curtis, Kenneth G. Saag, et al.. (2013). Cardiovascular Risk in Rheumatoid Arthritis: Comparing TNF-α Blockade with Nonbiologic DMARDs. The American Journal of Medicine. 126(8). 730.e9–730.e17. 89 indexed citations

19.

Brunelli, Steven M., Sushrut S. Waikar, Brian T. Bateman, et al.. (2012). Preoperative Statin Use and Postoperative Acute Kidney Injury. The American Journal of Medicine. 125(12). 1195–1204.e3. 39 indexed citations

20.

Choudhry, Niteesh K., Michael A. Fischer, Jerry Avorn, et al.. (2012). The Impact of Reducing Cardiovascular Medication Copayments on Health Spending and Resource Utilization. Journal of the American College of Cardiology. 60(18). 1817–1824. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact